Before treating the behavioural disturbance consider what may be causing it.
Assessment
Look for clues that the behaviour disturbance may be due to an organic cause, for example a previously stable elderly patient presenting with behaviour change may have sepsis, stroke, trauma or a drug interaction. The history is relevant, for example a patient with known epilepsy may present with post-ictal confusion, or a patient who is taking long-term anticoagulation may have had a head injury.
A general physical examination including neurological examination looking for higher function, orientation, meningism and localising signs should be performed as soon as possible. Measure the pulse, blood pressure, temperature, respiratory rate and if possible, oxygen saturation and blood glucose.
The clinical scenario will determine the extent of investigation required to exclude an organic cause or contributing comorbidity. Initial basic blood tests such as a full blood count, chemistry, blood sugar, liver and renal function are appropriate if results can be quickly obtained. Further tests including blood alcohol level, urine drug screen, urinalysis and culture and cerebral CT scanning may be required if the patient is hospitalised.
Common clues that a psychiatric cause is likely include past history of mental illness, drug use or alcoholism, current medications, general physical appearance including self-care, appropriateness of mood and engagement, manner and content of speech, posture and movement. Wherever possible collateral and corroborating history should be sought from family, friends and healthcare providers.
Non-pharmacological management
Some basic verbal de-escalation and distraction techniques can be used (see Box 2). It is often safer to call for help early and to remain at a safe distance until support, such as police and ambulance, arrives. A show of force may persuade the patient to cooperate.
Suspected or identified medical problems must be addressed before treating the behavioural disturbance. If the patient is uncooperative they may need to be scheduled if they are a danger to themselves or others and mental illness is suspected. While there are state by state differences in the Mental Health Act the principles are very similar. When involuntary care is needed, an initial schedule is written to allow safe care and transport to a mental health unit (this may be an emergency department, psychiatric unit or hospital). It should be remembered that in some jurisdictions a Mental Health Schedule can now be written by police and ambulance officers as well as by a doctor, and that it is a legal order that a patient be taken to a place where they can be assessed by a mental health specialist. If there is a potentially serious medical emergency it may be necessary to provide treatment without immediate scheduling of an uncooperative patient. Restraint and forced sedation should be considered a last resort.
Box 2
De-escalation
- Use an empathic non-confrontational approach, but set boundaries
- Listen to the patient, but avoid giving opinions on issues and grievances beyond your control
- Offer food, drink and a place to sit
- Avoid excessive stimulation
- Avoid aggressive postures and prolonged eye contact
- Recruit family, friends, case managers to help
- Address medical issues, especially pain and discomfort
- Try to ascertain what the patient actually wants and the level of urgency
Pharmacological management (Table 1)
In some situations sedation may be appropriate. The choice of drug and dosage used is influenced by the patient's age, size, other prescribed or non-prescribed drugs taken, known illness such as long-term benzodiazepine abuse, alcoholism, liver or renal failure.
Physical signs such as hypotension and hyperthermia indicate a need for resuscitation as well as adjustment of drug choice and dosage. Position the patient appropriately, for example lay them flat, elevate their legs if hypotensive, and ensure a safe airway position if they are post-ictal. When possible administer oxygen, intravenous fluids and glucose (plus thiamine if Wernicke's encephalopathy is a possibility). Gather information, continue to manage clinically and arrange transfer if indicated.
For disturbed patients, in the first instance an oral sedative should be offered in a non-threatening collaborative way: 'I know you feel very distressed and this will help while we work out what to do next'. Oral diazepam 5 mg or olanzapine 5 mg are common choices.
The dosage should be titrated to clinical effect whilst watching for over-sedation and other adverse effects such as hypotension in the patient who has ingested other drugs or alcohol, is dehydrated or has a medical illness.
Parenteral sedation is more difficult although a number of patients may accept this if it is offered: 'You will feel better far more quickly if I can give you this now'. Forced parenteral sedation is not usually possible outside hospital. It requires trained staff in numbers (usually five or more) to either convince the patient to accept without violent struggle or to restrain the patient while medication is given. This needs training and equipment such as gowns, gloves and face masks and requires some skill to avoid injury to the patient or staff.
All patients who have been given parenteral sedation will require a level of monitoring and ambulance transfer to hospital should be arranged as soon as possible. The need for transfer and monitoring becomes even more urgent when higher doses of benzodiazepines are used or when other drugs such as haloperidol have also been given.
Table 1 Drugs for sedation
Drug
|
Usual adult dose
|
Adverse events and management
|
Diazepam
|
5–10 mg oral or intravenously. Max 30 mg per event. Longer acting than midazolam.
|
Oversedation – maintain airway, coma position, provide oxygen
Hypotension – lay down, intravenous fluids
Airway or respiratory compromise – support airway, give oxygen
Parodoxical reactions
|
Lorazepam
|
2 mg. Max 10 mg in 24 hours.
|
Midazolam
|
5–10 mg intramuscularly. Max 20 mg per event. Rapid onset.
|
Olanzapine
|
5–10 mg oral. Max 30 mg per event.
|
Hypotension – lay down, intravenous fluids
Seizure – coma position, clear airway, benzodiazepines
|
Haloperidol
|
5–10 mg intramuscularly. Max 20 mg per event.
|
Acute dystonia – benztropine 2 mg oral or intramuscularly or intravenously
Hypotension – lay down, intravenous fluids
|
Benzodiazepines
Increasing doses of benzodiazepines produce a progressive spectrum of effect from anxiolysis and anticonvulsant effects to amnesia, sedation and eventually hypnosis and anaesthesia. Toxicity is usually related to very high doses and results in excessive sedation and airway obstruction. While benzodiazepines are essentially safe drugs, at very high doses or when given to a patient with hypovolaemia or other significant physiological compromise, they may contribute to cardiovascular and respiratory depression. Extra care should be taken if there is a possibility that the patient has consumed other sedating drugs (for example methadone).
Diazepam is used as an oral or intravenous preparation (not for intramuscular injection). It is quickly absorbed, but has a long half-life (up to 36 hours or more) so it can accumulate after repeated doses. Lorazepam has a shorter half-life (12–16 hours).
Midazolam is water-soluble and can be given intravenously or intramuscularly. It has a rapid onset, an elimination half-life of 2–4 hours and a much steeper dose-response curve than diazepam.
Antipsychotics
Olanzapine is an 'atypical antipsychotic' which can be given orally or as an intramuscular injection. It has a rapid onset of action with a half-life of about 30 hours. In clinical trials doses of 5–10 mg have been effective. A second dose should not be given for at least two hours. Olanzapine should not be given with benzodiazepines because of the risk of cardiorespiratory depression. Extrapyramidal effects may occur but are less likely than with typical antipsychotic drugs. Other potential adverse effects include excessive drowsiness, hypotension and tachycardia.
Haloperidol can be given as an intramuscular injection. It has a rapid onset of action with effects lasting two to four hours. Toxicity manifests as over-sedation or hypotension. There may be extrapyramidal adverse effects such as dystonia (or even neuroleptic malignant syndrome) and it may lower the seizure threshold.
Post-sedation management
In almost all circumstances the patient will need to be transferred for further medical and then psychiatric assessment as soon as possible. After sedation the patient must be closely observed and monitored. They should be managed in a safe position with a clear airway and if possible supplemental oxygen given. The degree of sedation (for example as assessed by the Glasgow Coma Score), pulse, temperature, blood pressure, respiratory rate and pupils should be checked. If equipment is available check the blood glucose (or give glucose if hypoglycaemia is possible but glucose cannot be checked), ECG rhythm and oxygen saturation. A physical examination looking for possible organic medical illness should be performed.
Arranging urgent transfer and managing a patient post-sedation is critical. An awareness of the potential adverse effects and possibility of overdosage is essential. Documentation including recorded observations is required.